China Medical Healthcare Stock Performance
| COLRF Stock | USD 0.08 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and China Medical are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days China Medical HealthCare has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, China Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 616.5 M | |
| Total Cashflows From Investing Activities | -185.1 M |
China |
China Medical Relative Risk vs. Return Landscape
If you would invest 8.00 in China Medical HealthCare on October 11, 2025 and sell it today you would earn a total of 0.00 from holding China Medical HealthCare or generate 0.0% return on investment over 90 days. China Medical HealthCare is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than China, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
China Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as China Medical HealthCare, and traders can use it to determine the average amount a China Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| COLRF |
Based on monthly moving average China Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Medical by adding China Medical to a well-diversified portfolio.
China Medical Fundamentals Growth
China Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of China Medical, and China Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Pink Sheet performance.
| Return On Equity | -0.0597 | |||
| Return On Asset | 0.0027 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 153.44 M | |||
| Shares Outstanding | 14.48 B | |||
| Price To Book | 0.30 X | |||
| Price To Sales | 0.07 X | |||
| Revenue | 1.46 B | |||
| EBITDA | 52.31 M | |||
| Cash And Equivalents | 544.61 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 316.41 M | |||
| Debt To Equity | 0.58 % | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | 219.42 M | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 3.49 B | |||
About China Medical Performance
By analyzing China Medical's fundamental ratios, stakeholders can gain valuable insights into China Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if China Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if China Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
China Medical HealthCare Group Limited, an investment holding company, primarily operates hospitals in the Peoples Republic of China, Australia, and the Philippines. China Medical HealthCare Group Limited was incorporated in 1990 and is headquartered in Wanchai, Hong Kong. China Medical is traded on OTC Exchange in the United States.Things to note about China Medical HealthCare performance evaluation
Checking the ongoing alerts about China Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for China Medical HealthCare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| China Medical generated a negative expected return over the last 90 days | |
| China Medical has some characteristics of a very speculative penny stock | |
| China Medical has high likelihood to experience some financial distress in the next 2 years | |
| China Medical HealthCare has accumulated 316.41 M in total debt with debt to equity ratio (D/E) of 0.58, which is about average as compared to similar companies. China Medical HealthCare has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist China Medical until it has trouble settling it off, either with new capital or with free cash flow. So, China Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Medical HealthCare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Medical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 1.46 B. Net Loss for the year was (137.3 M) with profit before overhead, payroll, taxes, and interest of 260.23 M. | |
| About 75.0% of China Medical shares are held by company insiders |
- Analyzing China Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China Medical's stock is overvalued or undervalued compared to its peers.
- Examining China Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China Medical's pink sheet. These opinions can provide insight into China Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for China Pink Sheet analysis
When running China Medical's price analysis, check to measure China Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Medical is operating at the current time. Most of China Medical's value examination focuses on studying past and present price action to predict the probability of China Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Medical's price. Additionally, you may evaluate how the addition of China Medical to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |